 |
Products |  |
Diseases | | Products |
|
Trials |  |
News |  |
- | BIO-106 / BiOneCure
New P1/2 trial, Combination therapy, Monotherapy, Metastases: StarBridge-1: A Study in Patients With Advanced Cancers (clinicaltrials.gov) - Apr 10, 2022
P1/2, N=332, Recruiting, Sponsor: BiOneCure Therapeutics Inc.